[HTML][HTML] Mesenchymal stem cell-based therapy of osteoarthritis: Current knowledge and future perspectives
CR Harrell, BS Markovic, C Fellabaum… - Biomedicine & …, 2019 - Elsevier
Osteoarthritis (OA) is a chronic, prevalent, debilitating joint disease characterized by
progressive cartilage degradation, subchondral bone remodeling, bone marrow lesions …
progressive cartilage degradation, subchondral bone remodeling, bone marrow lesions …
Improved therapeutics of modified mesenchymal stem cells: an update
DKW Ocansey, B Pei, Y Yan, H Qian, X Zhang… - Journal of translational …, 2020 - Springer
Abstract Background Mesenchymal stromal cells (MSCs) have attracted intense interest due
to their powerful intrinsic properties of self-regeneration, immunomodulation and multi …
to their powerful intrinsic properties of self-regeneration, immunomodulation and multi …
Trends in articular cartilage tissue engineering: 3D mesenchymal stem cell sheets as candidates for engineered hyaline-like cartilage
Articular cartilage defects represent an inciting factor for future osteoarthritis (OA) and
degenerative joint disease progression. Despite multiple clinically available therapies that …
degenerative joint disease progression. Despite multiple clinically available therapies that …
Mesenchymal stem cell-derived exosomes and MicroRNAs in cartilage regeneration: biogenesis, efficacy, miRNA enrichment and delivery
Exosomes are the small extracellular vesicles secreted by cells for intercellular
communication. Exosomes are rich in therapeutic cargos such as microRNA (miRNA), long …
communication. Exosomes are rich in therapeutic cargos such as microRNA (miRNA), long …
Mesenchymal stromal cells: heterogeneity and therapeutical applications
M Ouzin, G Kogler - Cells, 2023 - mdpi.com
Mesenchymal stromal cells nowadays emerge as a major player in the field of regenerative
medicine and translational research. They constitute, with their derived products, the most …
medicine and translational research. They constitute, with their derived products, the most …
[HTML][HTML] Factors affecting osteogenesis and chondrogenic differentiation of mesenchymal stem cells in osteoarthritis
Y Peng, H Jiang, HD Zuo - World journal of stem cells, 2023 - ncbi.nlm.nih.gov
Osteoarthritis (OA) is a common degenerative joint disease that often involves progressive
cartilage degeneration and bone destruction of subchondral bone. At present, clinical …
cartilage degeneration and bone destruction of subchondral bone. At present, clinical …
[HTML][HTML] The importance of physioxia in mesenchymal stem cell chondrogenesis and the mechanisms controlling its response
G Pattappa, B Johnstone, J Zellner, D Docheva… - International journal of …, 2019 - mdpi.com
Articular cartilage covers the surface of synovial joints and enables joint movement.
However, it is susceptible to progressive degeneration with age that can be accelerated by …
However, it is susceptible to progressive degeneration with age that can be accelerated by …
Hypoxic‐preconditioned mesenchymal stem cell‐derived small extracellular vesicles promote the recovery of spinal cord injury by affecting the phenotype of …
Z Yang, Z Liang, J Rao, H Xie, M Zhou… - CNS Neuroscience …, 2024 - Wiley Online Library
Background Secondary injury after spinal cord injury (SCI) is a major obstacle to their
neurological recovery. Among them, changes in astrocyte phenotype regulate secondary …
neurological recovery. Among them, changes in astrocyte phenotype regulate secondary …
Extracellular vesicles from mesenchymal stem cells as potential treatments for osteoarthritis
NA Mohd Noor, A Abdullah Nurul… - Cells, 2021 - mdpi.com
Osteoarthritis (OA) is a chronic degenerative disorder of the joint and its prevalence and
severity is increasing owing to ageing of the population. Osteoarthritis is characterized by …
severity is increasing owing to ageing of the population. Osteoarthritis is characterized by …
Assessment of the neuroprotective and stemness properties of human wharton's jelly-derived mesenchymal stem cells under variable (5% vs. 21%) aerobic conditions
E Tomecka, W Lech, M Zychowicz, A Sarnowska… - Cells, 2021 - mdpi.com
To optimise the culture conditions for human Wharton's jelly-derived mesenchymal stem
cells (hWJ-MSCs) intended for clinical use, we investigated ten different properties of these …
cells (hWJ-MSCs) intended for clinical use, we investigated ten different properties of these …